Join THIS FREE WEBINAR on Thursday April 11 @ 11 PST | 2 EST

Raphael Mechoulam: Adventures in Phytomedicine

A tribute to the Father of Cannabinoid Science

Join Ethan Russo, M.D. on this Free Webinar as he highlights Dr. Mechoulam’s extraordinary contribution to the field, their work together and personal reminiscences.

Thursday April 11 @ 11 PST | 2 EST

Register Now

"*" indicates required fields

Registration required to view the webinar

First Name **
Last Name **
This field is for validation purposes and should be left unchanged.
Raphel Mechoulam, PhD is the Father of Cannabinoid Science. Sadly, he passed in March 2023. His dear friend and colleague, Ethan Russo, M.D. will highlight Dr. Mechoulam’s extraordinary contribution to the field, their work together and personal reminiscences. Dr. Mechoulam discovered THC (tetrahydrocannabinol) and helped identify the key components of the endocannabinoid system (ECS). His groundbreaking work has transformed our understanding of cannabis and its effects on human health. Join us for this informative and heartfelt tribute.
Event Co-sponsored by

Credo Science & MM411

Introduction by Chris Devol
President of MM411
Ethan Russo, MD
Presentation by Ethan Russo
Founder/CEO of CReDO Science
Plus Q&A led by Nishi.


Israeli researcher Raphael Mechoulam, the father of cannabis research, passed away on March 10, 2023, at 92 years of age. In early 1960, he was the first to reveal the structure of cannabidiol (CBD) and delta 9-tetrahydrocannabinol (THC), molecules now used worldwide as medicine.1,2

In addition, Professor Mechoulam and his research group identified the endocannabinoid system, a biological system with endogenous neuromodulators that bind to specific receptors and are synthesized and metabolized by specific enzymes. It is now recognized that this system regulates various cognitive, physiological and pathophysiological processes, including immune system activity, memory, mood, pain, psychosis, etc. It also mediates the pharmacological effects of the cannabis plant.


Ethan Russo

Ethan Russo, MD, is a board-certified neurologist, psychopharmacology researcher, and author. He is the Founder/CEO of CReDO Science. He is a Past-President of the International Cannabinoid Research Society and is former Chairman of the International Association for Cannabinoid Medicines. He serves on the Scientific Advisory Board for the American Botanical Council. He is author of Handbook of Psychotropic Herbs, co-editor of Cannabis and Cannabinoids: Pharmacology, Toxicology and Therapeutic Potential, and author of The Last Sorcerer: Echoes of the Rainforest. He was founding editor of Journal of Cannabis Therapeutics, selections of which were published as books: Cannabis Therapeutics in HIV/AIDS, Women and Cannabis: Medicine, Science and Sociology, Cannabis: From Pariah to Prescription, and Handbook of Cannabis Therapeutics: From Bench to Bedside.

He has also published numerous book chapters, and over 70 peer-reviewed journal articles in neurology, pain management, cannabis, and ethnobotany. His research interests have included correlations of historical uses of cannabis to modern pharmacological mechanisms, phytopharmaceutical treatment of migraine and chronic pain, herbal synergy and phytocannabinoid/terpenoid, serotonergic and vanilloid interactions…  Learn More

Ethan Russo, MD